Skip to content
PICO Portalanswers from OpenAlex

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer

PaperCitations, authors & open-access status

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer have?

PICO Portalcitation count

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer has 122 citations in the OpenAlex counts PICO Portal stores.

When was Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer published?

PICO Portalyear

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer has 2013 year in the PICO Portal index.

What is the open-access status of Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer?

PICO Portaloa status

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer has green oa status in the PICO Portal index.

What is the DOI of Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer?

PICO Portaldoi

The DOI for Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer is on the source record.

What is the PMID of Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer?

PICO Portalpmid

The PMID for Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer is on the source record.

What is the OpenAlex record for Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer?

PICO Portalopenalex

The OpenAlex for Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial